Dr. Subham Banerjee

Dr. Subham Banerjee is an Associate Professor at the National Institute of Pharmaceutical Education and Research (NIPER) Guwahati, India. His research exclusively focuses on pharmacoengineering with the intervention of emerging technologies like pharmaceutical additive manufacturing (AM), new materials for AM & advanced DDS. His research group is actively engaged in developing innovative drug delivery platforms using advanced 3D/4D AM technologies, with particular emphasis on personalized, customized & smart/intelligent medicines with the aim to develop next-generation medicines. 

Presentation Topic :  “AM to PM: From Additive Manufacturing to Personalized Medicine”

Abstract :

Personalized medicines (PM) has gained much attention as an approach for customizing therapy for individual needs via Additive Manufacturing (AM). In pharmaceuticals, 3D/4D printing has been used to produce customized drug delivery systems and devices for personalized medicine. The popular 3D/4D printing technique used in pharmaceuticals is fused deposition modeling (FDM), stereolithography (SLA), selective laser sintering (SLS), semi-solid extrusion (SSE), direct powder extrusion (DPE), etc, has been explored by formulation scientists. With the advent of these platform technologies across the board, efforts have been made to improve the quality of human health. AM or 3D/4D printing is one such technology that can realize the long- due dreams of personalized drug delivery according to patient-specific requirements.